Janus Small/Mid Cap Growth Alpha ETF

  • JSMD

151 DETROIT STREET,
DENVER , CO, 80206

Rank

Rank Universe
2 11

Summary

The fund seeks to replicate the total return performance of the benchmark index, before fees and expenses, by investing in small-and mid-size companies in the United States.

The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team invests significantly in the secu More

Webiste

Directors

Jan 12, 2024
  • Jeffrey B. Weeden
  • Carrie Benz
  • Clifford J. Weber
  • Maureen T. Upton

Chief Compliance Officer

  • Kristin Mariani

Price

  • $ 80.81 ( -2.11 )
  • Dec 09, 2024
    Last Close
  • Net Assets
  • $313.4M
    Mar 21, 2024
  • 52-Week High/Low
  • $82.8 - $64.5

  • Expense Ratio
  • -

Performance

YTD

0%

3 Year

22.57%

5 Year

71.86%

Best

543.97%

2000

Worst

-27.31%

2008

Company Name

Holding

Incyte Corp. 2.86 %
Neurocrine Biosciences, Inc. 2.78 %
AppLovin Corp. 2.69 %
HEICO Corp. 2.67 %
Bio-Techne Corp. 2.51 %
Charles River Laboratories International, Inc. 2.45 %
Medpace Holdings, Inc. 2.31 %
Bentley Systems, Inc. 2.25 %
Rollins, Inc. 2.12 %
Bruker Corp. 1.94 %
More 1.94 %

Documents

Prospectus

link

Annual Reports

link

Fact Sheet

Q1 2022 Q4 2021 Q3 2021

NAV

Annual Return

Alpha - JSMD and S&P